News
This report describes a usually mild syndrome, dubbed LICATS, affecting about three-quarters of CAR T-cell recipients.
There's a vaccine for hepatitis B that, according to the CDC, can help to prevent millions of deaths worldwide.
2d
SurvivorNet on MSNTranscend NHL Study: Promising Long-Term Results for CAR T-Cell Therapy in Large B-Cell LymphomaLong-term data gathered from the TRANSCEND NHL trial have shown that this treatment approach can significantly improve survival.
From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...
When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...
Sydney scientists have revealed why receiving a booster vaccine in the same arm as your first dose can generate a more ...
Sophisticated imaging techniques have now revealed that when a booster vaccine is given in the same location, those ...
A fundamental discovery in how the immune system organizes itself to respond better to external threats,” researchers find in study.
A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...
During a live event, Nathan M. Denlinger, DO, MS, discussed the TRANSFORM trial of lisocabtagene maraleucel in B-cell ...
Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...
14d
Health and Me on MSNScientists Discover Gut Enzyme That Converts Blood Type A & B Into 'Universal Donor' Type OScientists discovered a gut enzyme that can convert A, B, and AB blood into universal Type O—revolutionizing transfusions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results